Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05710965
Other study ID # RV-003
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 15, 2023
Est. completion date June 9, 2023

Study information

Verified date June 2023
Source Revibe Technologies
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate and compare three different investigational wearable digital interventions to determine if they are helpful for improving symptoms and functioning in children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).


Description:

The study is a randomized controlled trial of three investigational wearable digital therapies. An online screening questionnaire will evaluate eligibility for the study. Parents and teachers will complete baseline measures, after which the child will wear the assigned device to school Monday-Friday for a four-week period. Parents and teachers will complete the measures again at the end of the four-week intervention period. Compliance with wearing the device will be monitored remotely.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date June 9, 2023
Est. primary completion date June 9, 2023
Accepts healthy volunteers No
Gender All
Age group 8 Years to 12 Years
Eligibility Inclusion Criteria: Youth Participants - Parent-reported diagnosis of ADHD - Must be between the ages of 8 and 12 years of age - Must live in the United States - Must be able to understand English well - Must be able to read English well (reading at grade level independently or with adult assistance) - Must be attending in-class (as opposed to hybrid or virtual) school during the period of the trial - Must be willing to wear the device to school on their wrist Monday to Friday for a period of four-weeks - Parent-rated ADHD-RS-5 Total score of = 28* - The ADHD-RS-5 score will be determined based on the ratings provided in the parent baseline questionnaire. Any youth with a parent-rated Total score <28 will be allowed to remain in the study but will not be included in the per protocol analyses. Parent Participants - Must be 18 years of age or older - Must be willing to invite the child's teacher to participate - Must live in the United States - Must read and understand English well - Must have a mobile device that can be used to download and install the software application and sync to the device - Must be willing to have their child wear the device to school Monday to Friday for a period of four weeks and sync and charge the device Teacher Participants - Must be 18 years of age or older - Must live in the United States - Must have known the student for at least four weeks - Must read and understand English well - Must be providing in person classroom learning to the youth during the study period Exclusion Criteria: Youth Participants - Motor condition (e.g., physical deformity of the hands/arms; prostheses) that prevents tapping the device if prompted or unable to feel vibrations from the device on their wrist (should there be any), as reported by the parent. - Home schooled - Diagnosed (parent-reported) Autism Spectrum Disorder, Intellectual Disability, Pervasive Developmental Disorder, Schizophrenia Spectrum Disorder. - Not undergoing pharmacological treatment for ADHD (currently or in the past 30 days) - Has ever worn or used Revibe Connect prior to the study or has a sibling who has - Has ever participated in a research study conducted by Revibe Technologies or has a sibling who has - Has a sibling participating in the study. Only one child per family is eligible to participate. - Allergy to latex (parent-reported) Parent and Teacher Participants • No exclusion criteria other than not meeting the inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Device:
FRx-001
Wearable digital therapy
FRx-003
Wearable digital therapy
FRx-004
Wearable digital therapy

Locations

Country Name City State
United States Revibe Technologies Wake Forest North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Revibe Technologies

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other ADHD Rating Scale-5, School Version: Hyperactivity-Impulsivity Subscale Nine teacher rated items aligned with DSM-5 Hyperactivity-Impulsivity symptoms, scored on a 4-point Likert scale. Scores range from 0-27, higher scores indicate greater symptom severity. Change from Baseline to Post-intervention (4 weeks)
Other ADHD Rating Scale-5, Home Version: Hyperactivity-Impulsivity Subscale Nine parent rated items aligned with DSM-5 Hyperactivity-Impulsivity symptoms, scored on a 4-point Likert scale. Scores range from 0-27, higher scores indicate greater symptom severity. Change from Baseline to Post-intervention (4 weeks)
Other Conners 4, Short Form: Parent Parent completed ratings of ADHD symptoms and functioning. Items are rated on a 4-point Likert scale. Subscale raw scores are converted to T-scores with a mean of 50 and standard deviation of 10. Higher scores indicate greater symptom severity or impairment. Change from Baseline to Post-intervention (4 weeks)
Other Conners 4, Short Form: Teacher Teacher completed ratings of ADHD symptoms and functioning. Items are rated on a 4-point Likert scale. Subscale raw scores are converted to T-scores with a mean of 50 and standard deviation of 10. Higher scores indicate greater symptom severity or impairment. Change from Baseline to Post-intervention (4 weeks)
Other Comprehensive Executive Function Inventory: Parent Parent completed ratings of a child's executive function. Consists of 9 domains and a total score. Items are rated on a 6-point Likert scale. Subscale raw scores are converted to standard scores with a mean of 100 and standard deviation of 15. Higher scores are indicative of better functioning. Change from Baseline to Post-intervention (4 weeks)
Other Comprehensive Executive Function Inventory: Teacher Teacher completed ratings of a child's executive function. Consists of 9 domains and a total score. Items are rated on a 6-point Likert scale. Subscale raw scores are converted to standard scores with a mean of 100 and standard deviation of 15. Higher scores are indicative of better functioning. Change from Baseline to Post-intervention (4 weeks)
Other Impairment Rating Scale - Parent Parent completed ratings of impairment in youth with ADHD. Parent version includes 8 items. The 8th represents overall impairment. Ratings are made on a 7-point Likert scale from "no problem/definitely does not need treatment or special services" to "extreme problem/definitely needs treatment or special services". Higher scores indicate more severe problems. Change from Baseline to Post-intervention (4 weeks)
Other Impairment Rating Scale - Teacher Teacher completed ratings of impairment in youth with ADHD. Teacher version includes 7 items. The 7th represents overall impairment. Ratings are made on a 7-point Likert scale from "no problem/definitely does not need treatment or special services" to "extreme problem/definitely needs treatment or special services". Higher scores indicate more severe problems. Change from Baseline to Post-intervention (4 weeks)
Other Weiss Functional Impairment Rating Scale - Parent Form Parent completed ratings of child's overall functioning across six domains including a total score. Items are rated on a 4-point Likert scale ranging from "not at all or never" to "very much or very often", as well as a "not applicable" option. Higher scores are associated with impairment. Change from Baseline to Post-intervention (4 weeks)
Other Academic Performance Rating Scale A 19-items scale developed to reflect teachers' perceptions of children'ts academic performance and abilities in classroom settings. Items are rated on a 5-point Likert scale, and scores are summed for each of the factor scores: Academic Success, Impulse Control, and Academic Productivity. A total score is also calculated for overall academic performance. Higher scores are representative of stronger classroom functioning. Change from Baseline to Post-intervention (4 weeks)
Primary ADHD Rating Scale-5 (ADHD-RS-5), School Version: Inattention Subscale Nine teacher rated items aligned with Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) Inattentive symptoms, scored on a 4-point Likert scale from "never or rarely" to "very often". Scores range from 0-27, higher scores indicate greater symptom severity. Change from Baseline to Post-intervention (4 weeks)
Secondary ADHD Rating Scale-5, Home Version: Inattention Subscale Nine parent rated items aligned with DSM-5 Inattentive symptoms, scored on a 4-point Likert scale from "never or rarely" to "very often". Scores range from 0-27, higher scores indicate greater symptom severity. Change from Baseline to Post-intervention (4 weeks)
Secondary ADHD Rating Scale-5, School Version: Total score Sum of the teacher rated Inattentive and Hyperactivity-Impulsivity Subscale scores. Scores range from 0-54, higher scores indicate greater symptom severity. Change from Baseline to Post-intervention (4 weeks)
Secondary ADHD Rating Scale-5, Home Version: Total score Sum of the parent rated Inattentive and Hyperactivity-Impulsivity Subscale scores. Scores range from 0-54, higher scores indicate greater symptom severity. Change from Baseline to Post-intervention (4 weeks)
See also
  Status Clinical Trial Phase
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Recruiting NCT06038942 - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress N/A
Not yet recruiting NCT06456372 - Digital Health Intervention for Children With ADHD N/A
Completed NCT05518435 - Managing Young People With ADHD in Primary Care Study
Active, not recruiting NCT04978792 - Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD? N/A
Completed NCT03216512 - Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD N/A
Completed NCT02900144 - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT) N/A
Not yet recruiting NCT02906501 - Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances N/A
Completed NCT02829528 - Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention N/A
Terminated NCT02271880 - Improving Medication Adherence in ADHD Adolescents N/A
Completed NCT02562469 - ACTIVATE: A Computerized Training Program for Children With ADHD N/A
Recruiting NCT02255565 - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study Phase 4
Completed NCT02463396 - Mindfulness Training in Adults With ADHD N/A
Terminated NCT01733680 - Amiloride Hydrochloride as an Effective Treatment for ADHD Early Phase 1
Completed NCT01673594 - Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Active, not recruiting NCT01137318 - Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) Phase 2
Completed NCT01404273 - Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder N/A
Completed NCT00573859 - The Reinforcing Mechanisms of Smoking in Adult ADHD Phase 1/Phase 2
Completed NCT00586157 - Study of Medication Patch to Treat Children Ages 6-12 With ADHD Phase 4